CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne
About this trial
Severe bacterial infections are a worldwide scourge. However, the epidemiology of this type of infection varies over time. It is therefore essential to monitor them in order to prevent them more effectively. At this time, in France, no monitoring exists for this kind of infections.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age <18 years (only hospitalized children)
Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment).
Disqualifiers
Refusal by one of the parents or by Child in understanding age
Nosocomial infection
Trial population
Children under 18 ages, with severe communautary invasive bacterial infections, hospitalized in pediatric intensive care unit.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
number of pediatrics cases of severe communautary bacterial infections
Proportion of hospitalized children in intensive care unit due to severe communautary bacterial infections
Time frame
1 year2
medical characterisation of children hospitalized for severe communautary bacterial infection case
Assessment of clinical, biological and microbiological characteristics of hospitalized children in intensive care unit due to severe communautary bacterial infections cases
Time frame
1 yearSecondary outcomes
1
Identify risk factors of serious infection
Describe what is responsible of serious infection
Time frame
1 year2
Identify predictive signs of severe cases in infected children.
what are the warning signs of a serious infection?
Time frame
1 year3
healthcare used for infected children
Describe healthcare provided during hospitalisation of infected children in order to manage this type of infection
Time frame
1 year4
Type of complications
Describe any complications due to infection
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Association Clinique Thérapeutique Infantile du val de Marne
Lead sponsor
GFRUP (Groupe Francophone de Réanimation et d'Urgences Pédiatrique)
Collaborator
Groupe de Pathologies Infectieuses Pédiatriques (GPIP)
Collaborator
Centre National de Référence des Streptocoques
Collaborator
Centre National de Référence des Pneumocoques
Collaborator
Centre National de Référence des Méningocoques et Haemophilus influenzae
Collaborator
Centre National de Référence des staphylocoques
Collaborator
Centre National de Référence des E. Coli
Collaborator
Source ClinicalTrials.gov